HealthDay Reports: Hydroxychloroquine Can Shorten Time to Recovery in COVID-19
A new study on the antimalarial drug hydroxychloroquine found that it can shorten body temperature recovery time and cough remission time versus standard treatment.
MONDAY, April 6, 2020 (HealthDay News) -- Hydroxychloroquine (HCQ) can shorten time to clinical recovery and promote pneumonia absorption among patients with coronavirus disease 2019 (COVID-19), according to a study that has not yet been peer reviewed and was posted online March 31 at medRxiv.org.
Zhaowei Chen, from the Renmin Hospital of Wuhan University in China, and colleagues examined the efficacy of HCQ in treatment of COVID-19. Sixty-two patients with COVID-19 diagnosed and admitted from Feb. 4 to Feb. 28, 2020, were randomly assigned to receive an additional five-day HCQ treatment or standard treatment (control).